I don’t get your logic. Unless a new CMC module is submitted and approved, Amphastar has to manufacture commercial Lovenox in the same manner as in the CMC section of its ANDA.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”